- PCRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $35.4 million.
- PCRX has traded 69,454 shares today.
- PCRX is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in PCRX with the Ticky from Trade-Ideas. See the FREE profile for PCRX NOW at Trade-Ideas More details on PCRX: Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products primarily for use in hospitals and ambulatory surgery centers worldwide. Currently there are 6 analysts that rate Pacira Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Pacira Pharmaceuticals has been 458,200 shares per day over the past 30 days. Pacira has a market cap of $3.1 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.23 and a short float of 20.6% with 10.46 days to cover. Shares are up 60% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.